Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The blood glucose monitoring market has witnessed significant trends and developments in recent years, reflecting the growing importance of managing diabetes and related conditions. One prominent trend is the increasing adoption of continuous glucose monitoring (CGM) systems. These devices provide real-time data on glucose levels, allowing individuals with diabetes to make informed decisions about their diet, medication, and lifestyle. The demand for CGM systems has surged due to their ability to offer a more comprehensive and detailed picture of glucose fluctuations compared to traditional methods.
Another noteworthy trend is the integration of technology in blood glucose monitoring devices. The market has seen a proliferation of smart glucose meters and apps that enable users to track and analyze their blood glucose levels conveniently. These technological advancements not only enhance user experience but also contribute to better diabetes management by providing actionable insights and personalized recommendations. The convergence of healthcare and technology has resulted in user-friendly interfaces, wireless connectivity, and data-sharing capabilities, making it easier for patients and healthcare professionals to collaborate in managing diabetes effectively.
Furthermore, there has been a notable shift towards minimally invasive blood glucose monitoring solutions. Continuous efforts are being made to develop non-invasive or less-invasive methods of monitoring glucose levels, reducing the discomfort associated with frequent blood sampling. Technologies such as wearable sensors and transdermal patches are gaining traction as they offer a more convenient and patient-friendly approach to blood glucose monitoring. This trend aligns with the broader healthcare industry's focus on improving patient compliance and quality of life.
The market also reflects a growing emphasis on personalized medicine in diabetes management. The one-size-fits-all approach is gradually giving way to customized solutions that take into account individual variations in response to treatment and lifestyle factors. This shift is driven by advancements in data analytics, genetic testing, and the understanding of the complex interplay of factors influencing blood glucose levels. Tailoring treatment plans based on individual characteristics enables more precise and effective management of diabetes, ultimately leading to better outcomes for patients.
Global awareness and initiatives promoting diabetes management and prevention have contributed significantly to the growth of the blood glucose monitoring market. Governments, healthcare organizations, and non-profit entities are actively engaged in creating awareness about the importance of regular monitoring, early detection, and proactive management of diabetes. This increased awareness has led to a higher demand for blood glucose monitoring devices, creating a positive impact on the market's growth.
EMEA Blood Glucose Monitoring Market Highlights:
EMEA Blood Glucose Monitoring Market Overview
EMEA Blood Glucose Monitoring Market Size was valued at USD 7.62 Billion in 2023. The EMEA Blood Glucose Monitoring industry is projected to grow from USD 8.03 Billion in 2024 to USD 14.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.99% during the forecast period (2024 - 2032).
One of the main objectives of diabetes treatment is to keep blood glucose level within a specified target range. Blood glucose monitoring is a process, which helps to identify the blood glucose level and notify if glucose level of blood is exceeding the limit. Thus, it helps to understand the food intake, exercise, insulin, and blood glucose level. The blood glucose monitoring devices provide useful information to manage diabetes. It helps to track the progress of treatment goal as well as monitor the effect of diabetes meditation on blood sugar level and understand the effect of illness and stress on the blood sugar level.
The EMEA blood glucose monitoring market is growing rapidly owing to the increasing prevalence of diabetes, innovative technology for monitoring and diagnosis of diabetes, early detection of diabetes, and increasing demand for continuous glucose monitoring devices.
Various blood glucose monitoring devices are available in the Europe and the Middle East and African market, which is referred as blood glucose meter. These devices help to identify the blood glucose level at home, clinics, hospitals, etc. Furthermore, they are designed to apply to the different type of diabetes such as Type 1 and Type 2.
Increasing diabetic patient in the Europe has increased the blood glucose monitoring devices market. Different types of glucose monitoring devices are available in the market such as blood glucose meter, continuous glucose monitoring system, Lancets, glucose monitoring strips, and others. Self-monitoring devices are the oldest method for monitoring blood glucose level and are widely used in home, hospital, and clinics.
EMEA Blood Glucose Monitoring Market Segment Insights
EMEA Blood Glucose Monitoring Product Type Insights
On the basis of the product type, the EMEA blood glucose monitoring market is segmented into invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices, and others.
Europe, the Middle East, and Africa Blood Glucose Monitoring Application Insights
On the basis of the application, EMEA blood glucose monitoring market is segmented into type 1 diabetes, type 2 diabetes, and others.
EMEA Blood Glucose Monitoring End User Insights
On the basis of the end user, EMEA blood glucose monitoring market is segmented into diagnostic centers, hospitals, clinics, research centers, and home care diagnostics.
Europe, the Middle East, and Africa Blood Glucose Monitoring Regional Insights
On the regional basis, Europe, Middle East, and Africa blood glucose monitoring market is segmented into two major regions Europe and the Middle East and Africa.
Europe blood glucose monitoring devices market is showing swift growth owing to the increasing diabetic and obese population, unhealthy food, lack of exercise, and many another factor. Europe is leading the market growth with 60% of market share of EMEA market. According to the WHO, in 2016, around 60 million people had diabetes, and its prevalence is increasing in all age groups in Europe.
The Middle East and Africa account for the least share of market owing to poor political conditions in Africa and limited availability of funds and availability of medical facilities but, sound growth is expected over the review period. The Middle East holds the major share of the Middle East & African market due to the presence of well-developed countries like Kuwait, Qatar, Oman and South Arabia. Whereas, African region is expecting a healthy growth due to the presence of a huge opportunity for the development of the market.
EMEA Blood Glucose Monitoring Market Key Players
Some of the key players in this market are:
- Abbott Laboratories (US)
- Arkay Inc. (Japan)
- Bayer Healthcare AG, (Germany)
- F.Hoffmann-La Roche (Switzerland)
- LifeScan
- Johnson & Johnson (U.S.)
- Medtronic plc.
- Nipro Diagnostics Inc.
- Terumo Medical Corporation
Intended Audience
- Blood Glucose Monitoring Devices Suppliers
- Blood Glucose Monitoring Devices Manufacturers
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
